Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Jun. 30, 2019
Current assets:    
Cash $ 197,622 $ 30,142
Accounts receivable (net of allowance of $0 and $0, respectively) 61,013 45,086
Inventories 275,605 406,439
Other current assets 398,085 1,000
Total current assets 932,325 482,667
Total assets 932,325 482,667
Current liabilities:    
Accounts payable 1,286,149 496,809
Accrued expense-related party 9,974 33,974
Accrued interest 192,625
Convertible notes payable-net of debt discounts and unamortized beneficial conversion feature 2,330,189 1,117,741
Fair value of derivative liabilities 1,590,638 1,306,748
Short-term borrowings- line of credit 3,897
Total current liabilities 5,413,472 2,955,272
Commitments and contingencies
Stockholders' deficit:    
Preferred stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of June 30, 2020 and 2019, respectively) 1 1
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 61,796,680 issued and outstanding as of June 30, 2020 and 53,773,856 issued and outstanding as of June 30, 2019, respectively) 61,797 53,774
Additional paid in capital 13,088,177 10,692,679
Accumulated deficit (17,631,122) (13,219,059)
Total stockholders' deficit (4,481,147) (2,472,605)
Total Liabilities and Stockholders' Deficit $ 932,325 $ 482,667